| 王新悦,朱 越,汪建民,步伟全,张镇峰.揿针联合蓝芩口服液治疗小儿急性扁桃体炎疗效及安全性[J].现代生物医学进展英文版,2020,(24):4739-4742. |
| 揿针联合蓝芩口服液治疗小儿急性扁桃体炎疗效及安全性 |
| Therapeutic Effect and Safety of Needle-embedding Therapy Combined with Lanqin Oral Liquid in Treating Acute Tonsillitis in Children |
| Received:July 06, 2020 Revised:July 28, 2020 |
| DOI：10.13241/j.cnki.pmb.2020.24.031 |
| 中文关键词: 揿针 蓝芩口服液 小儿急性扁桃体炎 疗效 安全性 |
| 英文关键词: Needle-embedding therapy Lanqin oral liquid Pediatric acute tonsillitis Efficacy Safety |
| 基金项目:江苏省中医药局科研项目（YB201819） |
|
| Hits: 669 |
| Download times: 380 |
| 中文摘要: |
| 摘要 目的：探讨揿针联合蓝芩口服液治疗小儿急性扁桃体炎疗效及安全性。方法：选取2018年6月至2019年12月江苏省第二中医院收治的96例急性扁桃体炎患儿，随机将其分为两组，对照组48例，给予蓝芩口服液治疗，研究组48例，给予揿针联合蓝芩口服液治疗。观察两组患儿的临床疗效、临床症状改善时间、治疗前后WBC、CRP、NEU水平以及不良反应率。结果：研究组总有效率显著高于对照组(97.92 % vs.83.88 %，P＜0.05)；研究组咽痛消失时间、扁桃体肿大消失时间、发热消失时间明显优于对照组(P＜0.05)；两组患儿治疗前WBC、CRP、NEU水平指标比较（P>0.05）；治疗后WBC、CRP、NEU水平指标比较（P<0.05）。研究组不良反应率显著低于对照组(2.08 % vs.16.67 %，P＜0.05)。结论：揿针联合蓝芩口服液治疗小儿急性扁桃体炎疗效显著，能有效的降低临床症状消失时间，控制炎症，减少不良反应发生率，安全可靠，值得临床推广和应用。 |
| 英文摘要: |
| ABSTRACT Objective: To explore the efficacy and safety of needle-embedding therapy combined with Lanqin oral liquid in the treatment of acute tonsillitis in children. Methods: A total of 96 children with acute tonsillitis admitted to Jiangsu Second Chinese Medicine Hospital from June 2018 to December 2019 were selected. They were randomly divided into two groups, 48 cases in the control group, and treated with Lanqin oral liquid, 48 cases in the study group, given needle-embedding therapy combined with Lanqin oral liquid treatment. Observe the clinical efficacy, clinical symptom improvement time, WBC, CRP, NEU levels and adverse reaction rate of the two groups of patients before and after treatment. Results: The total effective rate of the study group was significantly higher than that of the control group (97.92 %vs.83.88 %, P＜0.05). The disappearance time of sore throat, the disappearance time of tonsil enlargement and the disappearance of fever in the study group significantly better than the control group(P<0.05). Comparison of WBC, CRP, and NEU levels before treatment between the two groups of patients, the difference was not statistically significant (P>0.05). WBC, CRP, and NEU after treatment compared with the level indicators, the difference was statistically significant (P<0.05). The adverse reaction rate in the study group was significantly lower than that in the control group (2.08 % vs.16.67 %, P<0.05). Conclusion: Needle-embedding therapy combined with Lanqin oral liquid are effective in treating acute tonsillitis in children. They can effectively reduce the disappearance time of clinical symptoms, control inflammation, reduce the incidence of adverse reactions,are safe and reliable,and are worthy of clinical promotion and application. |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
